| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.
|
Gastroenterology
|
2003
|
3.58
|
|
2
|
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
|
Nat Rev Cancer
|
2010
|
3.27
|
|
3
|
Epidemiology and pathogenesis of esophageal cancer.
|
Semin Radiat Oncol
|
2007
|
3.18
|
|
4
|
Population attributable risks of esophageal and gastric cancers.
|
J Natl Cancer Inst
|
2003
|
3.07
|
|
5
|
Leukocyte telomere length predicts cancer risk in Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
2.39
|
|
6
|
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
|
PLoS Med
|
2007
|
2.23
|
|
7
|
Central adiposity and risk of Barrett's esophagus.
|
Gastroenterology
|
2007
|
2.20
|
|
8
|
Carbonated soft drink consumption and risk of esophageal adenocarcinoma.
|
J Natl Cancer Inst
|
2006
|
2.08
|
|
9
|
Racial disparities among patients with lung cancer who were recommended operative therapy.
|
Arch Surg
|
2009
|
2.02
|
|
10
|
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.
|
Gastroenterology
|
2006
|
1.98
|
|
11
|
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
|
Cancer Prev Res (Phila)
|
2010
|
1.89
|
|
12
|
Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma.
|
J Am Coll Surg
|
2010
|
1.68
|
|
13
|
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
|
Nat Genet
|
2013
|
1.67
|
|
14
|
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.
|
J Natl Cancer Inst
|
2010
|
1.60
|
|
15
|
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.
|
Nat Genet
|
2012
|
1.52
|
|
16
|
Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study.
|
Int J Epidemiol
|
2005
|
1.50
|
|
17
|
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
|
Gastroenterology
|
2011
|
1.44
|
|
18
|
Mouthwash use and cancer of the head and neck: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium.
|
Eur J Cancer Prev
|
2016
|
1.38
|
|
19
|
Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium.
|
Gut
|
2013
|
1.37
|
|
20
|
Chlamydia pneumoniae and lung cancer: epidemiologic evidence.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.31
|
|
21
|
Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies.
|
Cancer Causes Control
|
2002
|
1.31
|
|
22
|
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.
|
Cancer Prev Res (Phila)
|
2013
|
1.31
|
|
23
|
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium.
|
Int J Epidemiol
|
2012
|
1.30
|
|
24
|
Prior lung disease and risk of lung cancer in a large prospective study.
|
Cancer Causes Control
|
2004
|
1.30
|
|
25
|
Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
|
Clin Gastroenterol Hepatol
|
2013
|
1.29
|
|
26
|
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
|
Gastroenterology
|
2012
|
1.28
|
|
27
|
Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.
|
Semin Radiat Oncol
|
2013
|
1.28
|
|
28
|
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.
|
J Natl Cancer Inst
|
2013
|
1.25
|
|
29
|
Spectrum and risk of neoplasia in Werner syndrome: a systematic review.
|
PLoS One
|
2013
|
1.23
|
|
30
|
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers.
|
Clin Gastroenterol Hepatol
|
2005
|
1.21
|
|
31
|
A clinical risk prediction model for Barrett esophagus.
|
Cancer Prev Res (Phila)
|
2012
|
1.21
|
|
32
|
Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium.
|
Gut
|
2011
|
1.18
|
|
33
|
Chlamydia pneumoniae infection and risk of lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.18
|
|
34
|
Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
|
Obesity (Silver Spring)
|
2010
|
1.18
|
|
35
|
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals.
|
Gastroenterology
|
2010
|
1.18
|
|
36
|
Food group intake and risk of subtypes of esophageal and gastric cancer.
|
Int J Cancer
|
2008
|
1.17
|
|
37
|
Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
|
Clin Cancer Res
|
2009
|
1.17
|
|
38
|
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations.
|
Eur J Cancer Prev
|
2012
|
1.17
|
|
39
|
Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study.
|
Am J Gastroenterol
|
2009
|
1.14
|
|
40
|
Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002.
|
Am J Epidemiol
|
2005
|
1.13
|
|
41
|
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
|
PLoS One
|
2013
|
1.08
|
|
42
|
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations.
|
Eur J Cancer Prev
|
2009
|
1.07
|
|
43
|
Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.02
|
|
44
|
Cigarette smoking and risk of prostate cancer in middle-aged men.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.02
|
|
45
|
Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women.
|
Cancer Prev Res (Phila)
|
2011
|
1.00
|
|
46
|
Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries.
|
Int J Cancer
|
2014
|
0.99
|
|
47
|
Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
|
J Natl Cancer Inst
|
2003
|
0.99
|
|
48
|
GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas.
|
Cancer Detect Prev
|
2007
|
0.98
|
|
49
|
NSAIDs modulate clonal evolution in Barrett's esophagus.
|
PLoS Genet
|
2013
|
0.98
|
|
50
|
The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.
|
Cancer Epidemiol
|
2012
|
0.95
|
|
51
|
Survival differences by race in nasopharyngeal carcinoma.
|
Am J Epidemiol
|
2006
|
0.94
|
|
52
|
Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.94
|
|
53
|
Selenium, selenoenzymes, oxidative stress and risk of neoplastic progression from Barrett's esophagus: results from biomarkers and genetic variants.
|
PLoS One
|
2012
|
0.94
|
|
54
|
Association between use of specialty dietary supplements and C-reactive protein concentrations.
|
Am J Epidemiol
|
2012
|
0.93
|
|
55
|
Vegetable and fruit intakes and risk of Barrett's esophagus in men and women.
|
Am J Clin Nutr
|
2009
|
0.93
|
|
56
|
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.92
|
|
57
|
Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.90
|
|
58
|
Occupation and risk of esophageal and gastric cardia adenocarcinoma.
|
Am J Ind Med
|
2002
|
0.90
|
|
59
|
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
|
Nutr Cancer
|
2008
|
0.89
|
|
60
|
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas.
|
Cancer Causes Control
|
2007
|
0.89
|
|
61
|
Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view.
|
PLoS Comput Biol
|
2011
|
0.89
|
|
62
|
Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.
|
J Nutr
|
2012
|
0.89
|
|
63
|
Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.89
|
|
64
|
Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer.
|
Nutr Cancer
|
2013
|
0.88
|
|
65
|
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.
|
Cancer Causes Control
|
2008
|
0.88
|
|
66
|
Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.88
|
|
67
|
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.87
|
|
68
|
History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.87
|
|
69
|
A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer.
|
Lung Cancer
|
2003
|
0.86
|
|
70
|
Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage.
|
Cancer Causes Control
|
2014
|
0.85
|
|
71
|
Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium.
|
Eur J Epidemiol
|
2013
|
0.84
|
|
72
|
Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study.
|
Cancer Epidemiol
|
2012
|
0.83
|
|
73
|
Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer.
|
Eur J Cancer Prev
|
2011
|
0.82
|
|
74
|
Wood dust exposure and risk of lung cancer.
|
Occup Environ Med
|
2010
|
0.81
|
|
75
|
Gastric fluid bile concentrations and risk of Barrett's esophagus.
|
Interact Cardiovasc Thorac Surg
|
2007
|
0.79
|
|
76
|
Diet and upper gastrointestinal cancers: in search of dark matter.
|
Clin Gastroenterol Hepatol
|
2013
|
0.79
|
|
77
|
Risks of biliary tract cancer and occupational exposures among Shanghai women textile workers: a case-cohort study.
|
Am J Ind Med
|
2006
|
0.78
|
|
78
|
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
|
Int J Cancer
|
2009
|
0.78
|
|
79
|
Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers.
|
Clin Diagn Lab Immunol
|
2004
|
0.78
|
|
80
|
MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.
|
Am J Surg Pathol
|
2011
|
0.78
|
|
81
|
Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.78
|
|
82
|
Specialty supplement use and biologic measures of oxidative stress and DNA damage.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.77
|
|
83
|
Recent physical activity in relation to DNA damage and repair using the comet assay.
|
J Phys Act Health
|
2014
|
0.77
|
|
84
|
Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention.
|
BMC Med Inform Decis Mak
|
2014
|
0.77
|
|
85
|
Histologic Features Associated With Columnar-lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies From GERD Patients: A Community-based Population Study.
|
Am J Surg Pathol
|
2016
|
0.76
|